Procter & Gamble reported a 4% rise in first-quarter fiscal 2027 net sales to $23.3 billion, while growth in earnings per share was more modest. Its 22 October results put diluted EPS at $1.97, up 1%, and core EPS at $2.00, also up 1%. The useful distinction is between the sales increase, the profit that remained after costs, and the company’s separate adjusted earnings calculation.
The quarter covers July–September 2026. It is P&G’s first quarter of fiscal 2027, not the first calendar quarter of 2026. All monetary figures below are US dollars, and comparisons are against the equivalent prior-year quarter.
Sales, earnings and cash on different bases
| Measure | Current quarter | Comparison or basis | Official source |
|---|---|---|---|
| Net sales | $23.3 billion | $22.4 billion a year earlier; up 4% | Issuer financial tables |
| Organic sales growth | 4% | Excludes currency and acquisition/divestiture effects | Issuer financial tables |
| Diluted EPS, reported | $1.97 | $1.95 a year earlier; up 1% | Issuer financial tables |
| Core EPS, non-GAAP | $2.00 | $1.99 a year earlier; up 1% | Issuer financial tables |
| Net earnings | $4.8 billion | Reported quarterly accounting earnings | Issuer financial tables |
| Operating cash flow | $5.8 billion | Cash from operations; not net earnings | Issuer financial tables |
Why revenue and EPS did not grow at the same pace
Sales measure the value of products sold; earnings reflect the costs left after generating those sales. P&G said higher operating costs partly offset its sales increase. Its reported operating margin fell 70 basis points from a year earlier. A basis point is one-hundredth of a percentage point, so the decline was 0.70 percentage points, not a 70% fall.
Core EPS excludes specified items and is a non-GAAP measure. It supplements the $1.97 reported figure rather than replacing it. For comparisons over time, readers should keep reported EPS on one basis and core EPS on the other. Likewise, operating cash flow is not additional profit to be added to net earnings.
The annual sales update includes an acquisition
P&G updated its fiscal 2027 all-in sales-growth range to 2%–4%, reflecting its Thorne acquisition as of 1 October. It retained organic sales-growth guidance of 1%–3%. Organic growth removes currency movements and acquisitions or divestitures, helping distinguish changes in the existing business from changes in what the company owns.
The company also maintained core EPS growth guidance of flat to 3%, equivalent to $6.89–$7.11 per share. These figures concern the full fiscal year and remain management forecasts. They are not an additional quarter of earned income or an assured outcome.
P&G now forecasts an approximately $1.4 billion after-tax commodity-cost headwind for fiscal 2027. Actual costs, product demand and execution could differ from those assumptions. CapKet’s Lockheed Martin report offers another example of separating completed quarterly results from a forward-looking annual outlook.
Official sources and verification
Procter & Gamble results announcement (observed 2026-10-22T14:55:09.930Z); Procter & Gamble financial document (observed 2026-10-22T14:55:10.258Z). These are formats of the same issuer reporting, not independent corroboration. This is AI-assisted primary-document review, not independent human editorial approval.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.